| NCT Number | NCT06917339 |
| Lead Sponsor | Neuronetics |
| Conditions | Depression, Obsessive-Compulsive Disorder, Anxiety Depression |
| Enrollment | 156,000 participants |
| Start Date | 2025-02-25 |
| Primary Completion | 2035-12 (estimated) |
| Study Completion | 2035-12 (estimated) |
| Updated on ClinicalTrials.gov | 2026-04-09 |